Cash Flow Statement
Growth Metrics

Mimedx (MDXG) FCF Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5,389.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,525.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -341.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 43,511.00
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -336.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -336.00
Dec 31, 2025 -4.00
Sep 30, 2025 358.00
Jun 30, 2025 -1,152.00
Mar 31, 2025 -13.00
Dec 31, 2024 1,141.00
Sep 30, 2024 524.00
Jun 30, 2024 1,676.00
Mar 31, 2024 1,224.00
Dec 31, 2023 464.00
Sep 30, 2023 1,589.00
Jun 30, 2023 1,426.00
Mar 31, 2023 1,103.00
Dec 31, 2022 2,741.00
Sep 30, 2022 -827.00
Jun 30, 2022 -681.00
Mar 31, 2022 -318.00
Dec 31, 2021 -441.00
Sep 30, 2021 1,736.00
Jun 30, 2021 829.00
Mar 31, 2021 716.00
Dec 31, 2020 1,306.00
Sep 30, 2020 -446.00
Jun 30, 2020 -932.00
Mar 31, 2020 237.00
Dec 31, 2019 -3,086.00
Sep 30, 2019 -528.00
Jun 30, 2019 -1,631.00
Mar 31, 2019 -3,235.00
Dec 31, 2018 -2,278.00
Sep 30, 2018 -1,508.00
Jun 30, 2018 235.00
Mar 31, 2018 -701.00
Dec 31, 2017 -601.00
Sep 30, 2017 1,461.00
Jun 30, 2017 710.00
Mar 31, 2017 2,105.00
Dec 31, 2016 2,326.00
Sep 30, 2016 -950.00
Jun 30, 2016 578.00
Mar 31, 2016 -1,262.00
Dec 31, 2015 -948.00
Sep 30, 2015 -1,510.00
Jun 30, 2015 -63.00
Mar 31, 2015 1,543.00
Dec 31, 2014 -82.00
Sep 30, 2014 2,182.00
Jun 30, 2014 1,734.00
Mar 31, 2014 1,038.00
Dec 31, 2013 2,604.00
Sep 30, 2013 1,769.00
Jun 30, 2013 -159.00
Mar 31, 2013 1,596.00
Dec 31, 2012 7,074.00
Sep 30, 2012 3,107.00
Jun 30, 2012 10,076.00
Mar 31, 2012 14,750.00